pharmasia ltd
(523620:Bombay Stock Exchange)
pharmasia ltd (523620) Snapshot
|
Open
$18.83
|
Previous Close
$18.91
|
|
|
Day High
$19.05
|
Day Low
$18.83
|
|
|
52 Week High
05/20/13 - $21.50
|
52 Week Low
07/30/12 - $9.95
|
|
|
Market Cap
30.5M
|
Average Volume 10 Days
2.0K
|
|
|
EPS TTM
$4.73
|
Shares Outstanding
1.6M
|
|
|
EX-Date
--
|
P/E TM
4.0x
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
pharmasia ltd (523620) Related Businessweek News
No Related Businessweek News Foundpharmasia ltd (523620) Details
Phaarmasia Limited manufactures and sells pharmaceutical products and drugs in India and Nepal. The company offers pharmaceutical formulations, cosmetics, and creams. It also provides skin/face creams, tooth paste, and oral contraceptive pills. The company is based in Hyderabad, India.
pharmasia ltd (523620) Top Compensated Officers
pharmasia ltd (523620) Key Developments
Phaarmasia Limited, Board Meeting, May 29, 2013. Agenda: To consider audited results.
Phaarmasia Limited announced unaudited earnings results for the third quarter and nine months ended December 31, 2012. For the quarter, the company reported net sales/income from operations of INR 17.529 million against INR 40.085 million a year ago. Profit from operations before other income, interest and exceptional items was INR 2.523 million against INR 2.101 million a year ago. Profit from ordinary activities before tax was INR 2.531 million against INR 2.101 million a year ago. Net profit for the period was INR 2.063 million against INR 1.776 million or INR 0.26 per basic and diluted share a year ago. Total income from operations was INR 17.529 million against INR 40.085 million a year ago. For the nine months, the company reported net sales/income from operations of INR 44.295 million against INR 317.213 million a year ago. Profit from operations before other income, interest and exceptional items was INR 1.264 million against INR 6.915 million a year ago. Profit from ordinary activities before tax was INR 1.253 million against INR 6.928 million a year ago. Net profit for the period was INR 1.022 million or INR 0.15 per basic and diluted share against INR 6.268 million or INR 0.92 per basic and diluted share a year ago. Total income from operations was INR 44.349 million against INR 317.213 million a year ago.
Phaarmasia Limited, Board Meeting, Feb 12, 2013. Agenda: To consider quarterly results.

| Recently Viewed | |||
| PHRM:IN | 15.15 INR | 0.00 | |
| Company | Last | Change | |
| No competitor information is available for 523620. | |||
| View Industry Companies | |||
Industry Analysis
523620
Industry Average
| Valuation | 523620 | Industry Range |
| Price/Earnings | 54.4x |
|
| Price/Sales | 1.4x |
|
| Price/Book | 1.3x |
|
| Price/Cash Flow | 15.9x |
|
| TEV/Sales | 1.4x |
|
Post a JobJobs
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
- Orlando, FL | Consult SoftPosted: May 22
Sponsored Financial Commentaries
Sponsored Links
To contact PHARMASIA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








